Currently, there are 340.59M common shares owned by the public and among those 288.05M shares have been available to trade.
The company’s stock has a 5-day price change of 8.47% and 30.38% over the past three months. K shares are trading 43.55% year to date (YTD), with the 12-month market performance up to 39.24% higher. It has a 12-month low price of $47.62 and touched a high of $80.46 over the same period. K has an average intraday trading volume of 3.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.60%, 30.49%, and 40.23% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Kellanova Co (NYSE: K) shares accounts for 74.12% of the company’s 340.59M shares outstanding.
It has a market capitalization of $27.47B and a beta (3y monthly) value of 0.34. The stock’s trailing 12-month PE ratio is 30.50, while the earnings-per-share (ttm) stands at $2.63. The company has a PEG of 3.53 and a Quick Ratio of 0.48 with the debt-to-equity ratio at 1.97. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.55% over the week and 2.19% over the month.
Earnings per share for the fiscal year are expected to increase by 16.60%, and 5.15% over the next financial year. EPS should grow at an annualized rate of 8.64% over the next five years, compared to -6.41% over the past 5-year period.
Goldman coverage for the Kellanova Co (K) stock in a research note released on August 12, 2024 offered a Neutral rating with a price target of $75. RBC Capital Mkts was of a view on August 05, 2024 that the stock is Outperform, while Exane BNP Paribas gave the stock Outperform rating on August 05, 2024, issuing a price target of $74. BofA Securities on their part issued Buy rating on August 02, 2024.
